Biogenetic Drugs Private Limited

Biogenetic Drugs Private Limited - pharma in Jaipur, Rajasthan, India. FY 2026 financials & compliance.
CIN U24232RJ2004PTC018909 Incorporated 23 January 2004 ROC Jaipur HQ Jaipur, Rajasthan, India
Active Private Limited Company pharma MSME · Medium
Revenue · FY 2025
₹115.34 Cr
▼ 2% YoY
Net profit · FY 2025
₹3.43 Cr
Net margin 3%
EBITDA · FY 2025
₹8.21 Cr
EBITDA margin 7.1%
Authorised capital
₹3 Cr
Registered with MCA
Paid-up capital
₹2.94 Cr
Issued & subscribed
Open charges
₹36.25 Cr
Satisfied ₹26.71 Cr
Company age
22 yrs
Est. 2004
Directors on board
3
As per MCA filings

About Biogenetic Drugs Private Limited

Data last updated:

Biogenetic Drugs Private Limited is a private limited company based in Jaipur, Rajasthan, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 23 January 2004 and has been in existence for over 22 years.

The company is registered with the Registrar of Companies (ROC), Jaipur, under CIN U24232RJ2004PTC018909. Its GSTIN is 08AACCB3897K1Z7 (Rajasthan). The company holds 5 GST registrations, all of them active.

The company has an authorised share capital of ₹3 Cr and a paid-up capital of ₹2.94 Cr. It is led by directors including Vibhor Goyal and Mukut Bihari Goyal.

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 66 Mathur Vaish Nagartonk Road, Jaipur, Rajasthan, India.

As per the financials filed for FY 2025, the company reported a revenue of ₹115.34 Cr, a decline of 2% compared to the previous year. For the same year it recorded a net profit of ₹3.43 Cr (net margin 3%) and EBITDA of ₹8.21 Cr (EBITDA margin 7.1%). Revenue has grown at a compounded annual rate (CAGR) of 23% over three years and 3% over five years.

As per MCA filings, the company has open charges of ₹36.25 Cr and satisfied charges of ₹26.71 Cr on record. Court records list 242 cases involving the company, including 152 filed by the company and 90 filed against it; 55 cases are pending. The company has 6 deals on record (4 funding rounds, 2 secondary share transfers), with disclosed funding of ₹3.74 Cr; the latest was in May 2010. Its 8 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 4 smaller; the largest is Crius Life Sciences Private Limited with revenue of ₹116.77 Cr. The company has 4 MSME Form 1 returns on record between 2019 and 2021, listing 303 overdue payments to 53 micro and small suppliers.

Biogenetic Drugs Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-RJ-17-0051306). The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U24232RJ2004PTC018909
Registration Number 018909
Incorporation Date 23 January 2004
ROC Jaipur
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-RJ-17-0051306
Key People
Raj Kumar Additional Director Vibhor Goyal Director Mukut Bihari Goyal Director

Recognitions & Rankings of Biogenetic Drugs

MSME (Udyam registered) Ministry of MSME
Category
Medium (2023-24)
Udyam number
UDYAM-RJ-17-0051306

Contact details

Biogenetic Drugs Private Limited's registered office is in Jaipur, Rajasthan. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    66 Mathur Vaish Nagartonk Road, Jaipur, Rajasthan, India
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Biogenetic Drugs Private Limited, buy the company report.

Comprehensive company report
Biogenetic Drugs Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Biogenetic Drugs is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Biogenetic Drugs Private Limited, buy the company report.

Financials of Biogenetic Drugs Private Limited

FY 2024 filings available

Biogenetic Drugs Private Limited reported revenue of ₹115.34 Cr (down 2% YoY) for FY 2025.

Revenue · FY 2025
₹115.34 Cr ▼ 2%
Net profit · FY 2025
₹3.43 Cr margin 3%
EBITDA · FY 2025
₹8.21 Cr margin 7.1%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 2%
3 years · compounded
▲ 23%
5 years · compounded
▲ 3%
EBITDA CAGR growth
1 year
▼ 25%
5 years · compounded
▼ 1%

Revenue fell 2% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 3%. EBITDA fell 25% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹8.21 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹3.43 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin7.1%
Net Profit Margin3%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Biogenetic Drugs Private Limited, buy the company report.

Board of directors of Biogenetic Drugs Private Limited

Biogenetic Drugs has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Raj Kumar
Also directs: Cynamid Pharmachem LLP
Additional Director27 Feb 20251 Years 8 MonthsCurrent
Vibhor Goyal
Also directs: Smilax Psyllium Impex LLP, Cynamid Pharmachem LLP
Director21 Jan 201214 Years 9 MonthsCurrent
Mukut Bihari Goyal
Also directs: Smilax Psyllium Impex LLP, Cynamid Pharmachem LLP, Shiana Impex LLP and 5 more
Director23 Jan 200422 Years 9 MonthsCurrent
View all directors

Peer comparison

Biogenetic Drugs Private Limited is compared with the 8 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Crius Life Sciences Private Limited₹116.77 Cr (FY 2025)3.0%Nalagarh, Himachal Pradesh, India
Kerala State Drugs and Pharmaceuticals Ltd₹116.23 Cr (FY 2024)41.0%Alappuzha, Kerala, India
Ar-Ex Laboratories Private Limited₹115.46 Cr (FY 2025)16.0%Mumbai, Maharashtra, India
Pharose Remedies Limited₹115.39 Cr (FY 2025)4.0%Punjab, India
Biogenetic Drugs Private Limitedthis company₹115.34 Cr (FY 2025)₹3.43 Cr3%-2.0%Jaipur, Rajasthan, India
Synthokem Labs Private Limited₹113.98 Cr (FY 2024)2.0%Patancheru, Telangana, India
Savorite Pharmaceuticals Private Limited₹113.71 Cr (FY 2025)-12.0%Vadodara, Gujarat, India
Socomed Pharma Private Limited₹113.64 Cr (FY 2025)-20.0%Mumbai, Maharashtra, India
Seagull Pharmaceuticals Pvt Ltd₹113.36 Cr (FY 2025)8.0%Naraina Vihar, Delhi, India

To see the full peer comparison of Biogenetic Drugs Private Limited, buy the company report.

Auditor

Biogenetic Drugs Private Limited is audited by S.R. SURANA & CO. for the financial year 2024.

Auditor firmFinancial yearFirm registration number
S.R. SURANA & CO.FY 2024000990C

Shareholding

The shareholding of Biogenetic Drugs Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2024FY 2023FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Biogenetic Drugs Private Limited, buy the company report.

Charges & borrowings

Open charges
₹36.25 Cr
Satisfied charges
₹26.71 Cr
Breakdown by lending institutions
State Bank of India₹36.25 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
23 May 2023100721936State Bank of India₹7.25 CrOpen
30 Oct 2017100149810State Bank of India₹29 CrOpen
14 Mar 2017100085005Sidbi₹3.1 CrSatisfied
11 Nov 201110320757Small Industries Development Bank of India₹35 LakhSatisfied
21 Apr 201110285226Union Bank of India₹1.1 CrSatisfied

To see the full charge records of Biogenetic Drugs Private Limited, buy the company report.

Total charge records: 10 View all charges

Deals & funding

Biogenetic Drugs Private Limited has 6 deals on record (4 funding rounds, 2 secondary share transfers), with disclosed funding of ₹3.74 Cr; the latest was in May 2010.

Total deals
6
Funding rounds
4
Secondary share transfers
2
Disclosed funding
₹3.74 Cr

Deals on record (5 of 6)

WhenDealAmountParties
May 2010Secondary share transferUndisclosedBuyer: Wright Care Remedies Private Limited , an individual
Seller: Parishudh Finance Co. Private Limited, Hillridge Investments Limited , Meadow Venture Private Limited , an individual
Mar 2009Funding round₹85 LakhInvestors: Victory Sales Private Limited , Alka Diamond Industries Limited , Meadow Venture Private Limited
Mar 2008Funding round₹40 LakhInvestors: Sanjivani Enviro Protection Limited , Anehal Properties Private Limited, Raghunandan Rayons Limited
Mar 2007Funding round₹50 LakhInvestors: Alka Diamond Industries Limited , Javda India Impex Limited , S R Cables Private Limited , an individual
Nov 2006Funding round₹1.99 CrInvestors: 2 individuals

To see the full deal history of Biogenetic Drugs Private Limited, buy the company report.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

Credit ratings & regulatory alerts

Biogenetic Drugs Private Limited was last rated by Brickwork on 11 Feb 2022.

Rating agencyRated onRating
Brickwork11 Feb 2022

To see the full credit ratings and regulatory alerts of Biogenetic Drugs Private Limited, buy the company report.

MSME payment delays

Biogenetic Drugs Private Limited has 4 MSME Form 1 returns on record between 2019 and 2021, listing 303 overdue payments to 53 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 53)

SupplierAmount dueDue sinceReported on
Zefe Labs (I) Private Limited
Corel Pharma Chem
Surya Vinyl Private Limited
an individual supplier
Sea-Shell Chemicals Private Limited

To see the full MSME payment records of Biogenetic Drugs Private Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

GST

Biogenetic Drugs has 5 GST registrations: 5 active. The first 4 active GSTINs are listed below.

Total GSTINs
5
Active
5
GSTINStateStatusRegistered on
08AACCB3897K1Z7RajasthanActive01 Jul 2017
02AACCB3897K1ZJHimachal PradeshActive01 Jul 2017
09AACCB3897K1Z5Uttar PradeshActive01 Jul 2017
36AACCB3897K1Z8TelanganaActive15 Jan 2025

To see the full GST registrations and return filing status of Biogenetic Drugs Private Limited, buy the company report.

Recent activity

Biogenetic Drugs Private Limited has 6 board changes on record since 2004: 3 appointments and 3 cessations. The latest: Raj Kumar was appointed as Additional Director on 27 Feb 2025.

Appointed
Raj Kumar was appointed as Additional Director.
Charges
A charge with State Bank Of India of Rs. 29.00 Cr registered on 30 Oct 2017 with Charge ID 100149810 was modified on 15 Feb 2025.
AGM
Biogenetic Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Biogenetic Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Jaipur.
Charges
A charge with State Bank Of India amounted to Rs. 7.25 Cr with Charge ID 100721936 was registered on 23 May 2023.
Charges
A charge registered on 21 Apr 2011 via Charge ID 10285226 with Union Bank Of India was fully satisfied on 15 Oct 2018.
Charges
A charge registered on 16 Mar 2011 via Charge ID 10278977 with Union Bank Of India was fully satisfied on 31 Jul 2018.
Ceased
Mukta Goyal ceased to be Director.
Charges
A charge registered on 06 Jan 2009 via Charge ID 10139486 with Dy Director Of Industries was fully satisfied on 07 Feb 2018.
Charges
A charge registered on 14 Mar 2017 via Charge ID 100085005 with Sidbi was fully satisfied on 17 Jan 2018.
Charges
A charge with State Bank Of India amounted to Rs. 29.00 Cr with Charge ID 100149810 was registered on 30 Oct 2017.
Charges
A charge with Sidbi amounted to Rs. 3.10 Cr with Charge ID 100085005 was registered on 14 Mar 2017.

20 earlier events are in the company report.

Frequently asked questions

Biogenetic Drugs is an active private limited company based in Jaipur, Rajasthan, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 23 January 2004 (22+ years old) and is registered under CIN U24232RJ2004PTC018909.

Biogenetic Drugs has 3 current directors:

The latest financial statements of Biogenetic Drugs on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.

The GSTIN of Biogenetic Drugs is 08AACCB3897K1Z7, registered in Rajasthan. The company has 5 GST registrations in all, of which 5 are active. Other active GSTINs include 02AACCB3897K1ZJ (Himachal Pradesh), 09AACCB3897K1Z5 (Uttar Pradesh), 36AACCB3897K1Z8 (Telangana).

The CIN (Corporate Identification Number) of Biogenetic Drugs is U24232RJ2004PTC018909. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Biogenetic Drugs has 242 court cases on record: 152 filed by the company and 90 filed against it. 55 are pending. Most are in the high courts.

Biogenetic Drugs was incorporated on 23 January 2004, making it 22+ years old. It is registered with the Registrar of Companies, Jaipur.

Biogenetic Drugs has 6 deals on record (4 funding rounds, 2 secondary share transfers), with disclosed funding of ₹3.74 Cr; the latest was in May 2010.

The peers of Biogenetic Drugs by revenue are Crius Life Sciences Private Limited, Kerala State Drugs and Pharmaceuticals Ltd, Ar-Ex Laboratories Private Limited, Pharose Remedies Limited, Synthokem Labs Private Limited and 3 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Raj Kumar was appointed as Additional Director on 27 Feb 2025. Mukta Goyal ceased to be Director on 15 Mar 2018. Updesh Yadav ceased to be Additional Director on 30 Sep 2015. Biogenetic Drugs has 6 board changes on record in total.

Yes, Biogenetic Drugs is registered as a medium enterprise under Udyam registration (number: UDYAM-RJ-17-0051306).

Biogenetic Drugs has 4 MSME Form 1 returns on record between 2019 and 2021, listing 303 overdue payments to 53 micro and small suppliers. The latest return was filed on 14 Dec 2021.